Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline. 1993

L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
Department of Immunology, Nephrology, and Medical Genetics, Hôpital Erasme and IRIBHN, Université Libre de Bruxelles, Belgium.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
July 1999, Clinical and diagnostic laboratory immunology,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
April 1993, Transplantation proceedings,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
February 1994, Transplantation,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
September 1989, Lancet (London, England),
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
December 1996, Transplantation,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
January 1993, Nephron,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
January 1996, European journal of immunology,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
December 1992, Transplantation proceedings,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
August 2001, Biomaterials,
L Schandené, and C Gérard, and A Crusiaux, and D Abramowicz, and T Velu, and M Goldman
April 1996, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!